JESSICA VINAS: Open Payments
NPI 1528555406 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 117 payments from 26 companies in 2025. Trend: 2023 $1,519 · 2024 $3,936 · 2025 $2,279
Food & beverage: $2,279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $258 |
| IBSA Pharma Inc. | 3 | $217 |
| Lilly USA, LLC | 11 | $215 |
| ABBVIE INC. | 17 | $210 |
| Sequel Med Tech, LLC | 9 | $171 |
| Xeris Pharmaceuticals, Inc. | 8 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $139 |
| Amgen Inc. | 6 | $103 |
| Insulet Corporation | 4 | $96 |
| Corcept Therapeutics | 4 | $87 |
Products named: Tirosint, JARDIANCE, Ozempic, TWIIST, Kerendia, RECORLEV, Omnipod, Korlym.
Industry payments across TN — which companies pay providers there.
